Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cytoplasmic membrane is a fundamental phospholipid bilayer that separates the cytoplasm from the external environment or the periplasm (Source: PMID: 25611371). It plays a critical role in maintaining the electrochemical gradient, facilitating nutrient transport, and anchoring proteins involved in cell wall synthesis and energy production. Many antimicrobial agents, such as lipopeptides and polymyxins, target this structure by inducing channel formation or physical disruption of the bilayer (Source: PMID: 28130388). This process leads to the rapid efflux of essential ions like potassium, resulting in membrane depolarization and the inhibition of DNA, RNA, and protein synthesis (Source: PMID: 24037461). Because the composition of bacterial membranes differs significantly from mammalian membranes—notably in the presence of negatively charged phospholipids and the absence of sterols—it serves as a viable target for selective toxicity. However, systemic use of such drugs is often limited by potential toxicity to host tissues, such as nephrotoxicity or myopathy. The formation of channels specifically bypasses traditional resistance mechanisms like efflux pumps, making it a potent strategy against multi-drug resistant organisms.
Induction of transmembrane channel formation or pore creation leading to ion leakage, membrane depolarization, and loss of cellular homeostasis.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cytoplasmic membrane phospholipid bilayer.